BPC-157 Import Supplier — Australia
Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.
Aarise Healthcare exports BPC-157 (CAS: 137525-51-0) to research institutions in Australia. Our WHO-GMP certified facility in India supplies 98%+ purity BPC-157 for tissue repair and regeneration research.
BPC-157 Export Specifications for Australia
| Compound | BPC-157 |
| CAS Number | 137525-51-0 |
| Purity | 98%+ (HPLC verified) |
| Form | Lyophilised powder |
| Regulatory Reference | TGA |
| Shipping | DHL/FedEx temperature-controlled |
| Transit to Australia | 5-10 business days |
| Documentation | CoA, HPLC, MS, export docs |
Research Applications of BPC-157
BPC-157 is used in tissue repair and regeneration research. Research institutions in Australia source this compound for preclinical studies under applicable TGA research regulations.
Why Australia Researchers Source BPC-157 from India
- WHO-GMP certified Indian manufacturer — internationally recognised compliance
- Competitive pricing for bulk research quantities
- Full export documentation package for TGA compliance
- Temperature-controlled DHL/FedEx shipping to Australia
- Dedicated international research supply team
- 98%+ purity guaranteed with independent third-party CoA
Related Peptides in Australia
Semaglutide in Australia | Tirzepatide in Australia | Retatrutide in Australia | Liraglutide in Australia
BPC-157 — Other Countries
BPC-157 in USA | BPC-157 in UK | BPC-157 in Germany | BPC-157 in Canada
Source from India — Key Manufacturing Cities
BPC-157 in Mumbai, India | BPC-157 in Delhi, India | BPC-157 in Hyderabad, India | BPC-157 in Bangalore, India
Request BPC-157 for your Australia research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.
